TWP
IART icon

TFO Wealth Partners’s Integra LifeSciences IART Stock Holding History

TFO Wealth Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5
Closed -$206 – 1002
2023
Q3 		$206 Buy
+5
New +$210 ﹤0.01% 788

Other funds holding IART

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TFO Wealth Partners's IART Position: Q4 2023 in Review

TFO Wealth Partners sold out of Integra LifeSciences (IART) in Q4 2023, closing a stake of 5 shares — an estimated $206 sold.

TFO Wealth Partners first reported a position in IART in Q3 2023 and held it in 1 quarter. The position peaked at $206 in Q3 2023. 284 funds tracked by Wall St. Rank hold IART as of Q4 2023.

  • TFO Wealth Partners reported no remaining Integra LifeSciences position as of Q4 2023 after selling out during the quarter.
  • TFO Wealth Partners sold 5 Integra LifeSciences shares in Q4 2023, an estimated $206.
  • TFO Wealth Partners first reported a position in Integra LifeSciences in Q3 2023 and held it in 1 quarter.
  • TFO Wealth Partners's Integra LifeSciences position peaked at $206 in Q3 2023.
  • 284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2023.

Based on TFO Wealth Partners's 13F filing for Q4 2023, filed 12 Feb 2024.